Clinical Trials Logo

ADHD clinical trials

View clinical trials related to ADHD.

Filter by:

NCT ID: NCT04027361 Completed - ADHD Clinical Trials

Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)

Start date: October 1, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the effect on driving performance of a single dose of amphetamine extended-release tablets (20 mg/tablet) compared with placebo at 45 minutes and 10 hours post-dose in young adults with ADHD.

NCT ID: NCT04016792 Withdrawn - ADHD Clinical Trials

Classroom Study of SPN-812 in Children With ADHD

Start date: August 2019
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of SPN-812, an extended-release formulation of viloxazine, compared to placebo in children in an analog classroom setting.

NCT ID: NCT04002167 Completed - ADHD Clinical Trials

A Novel fNIRS Neurofeedback Intervention for Enhancement of Working Memory in Attention Deficit Hyperactivity Disorder (ADHD)

Start date: August 16, 2019
Phase: N/A
Study type: Interventional

The proposed study is to test and validate a novel intervention that integrates computerized cognitive training with real-time neuromonitoring and neurofeedback to enhance working memory by probing the individualized neural systems underlying working memory. We will test the proposed intervention on children with ADHD with working memory deficits. The R61 proof-of-concept phase will assess the target engagement, effective dose and feasibility.

NCT ID: NCT03955692 Completed - ADHD Clinical Trials

The Efficacy of Cathodal tDCS in ADHD

Start date: December 15, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effectiveness of five sessions of cathodal tDCS over the left DLPFC on inhibitory control/response inhibition in children and adolescents with ADHD. Investigators hypothesize that multiple sessions of cathodal tDCS will induce a greater and long-term effect on inhibitory response in children and adolescents with ADHD.

NCT ID: NCT03917953 Completed - ADHD Clinical Trials

Transcutaneous Electrical Acupoint Stimulation for the Treatment of ADHD

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

RATIONALE: Transcutaneous electrical acupoint stimulation may improve attention deficit hyperactivity disorder (ADHD). PURPOSE: This randomized-controlled trial study of treating attention deficit hyperactivity disorder of school-aged children with transcutaneous electrical acupoint stimulation to see how well it works compared to sham transcutaneous electrical acupoint stimulation.

NCT ID: NCT03917316 Completed - ADHD Clinical Trials

Language Abilities of Children With ADHD

Start date: May 1, 2018
Phase:
Study type: Observational

BACKGROUND: Attention-Deficit/Hyperactivity-Disorder (ADHD) is associated with language difficulties within expressive, receptive and pragmatic areas of language.Telling stories is a particularly interesting language task as is provides the possibility of investigating how children use their language in everyday interactions. Thus, investigating how children with ADHD tell stories provides a more naturalistic impression of their language abilities. However, the extent, causes, and clinical relevance of language and narrative difficulties in ADHD remain largely unknown. Language may be the key to understanding and improving the functional impairments associated with ADHD such as social and academic function. AIM: The overall aim of the current study was to investigate the association between language, narrative ability and ADHD, what contributes to this association, as well as the clinical relevance of language difficulties in ADHD in relation to academic and social function. METHOD: Children between 7-11 years old with ADHD will be recruited from Aarhus University Hospital in Skejby and compared to children without ADHD recruited from schools in the community. All children will be assessed at two separate meetings at the Department of Psychology, Aarhus University. The total number of participants in each group will depend on the intake of patients at Aarhus University Hospital, but a maximum of 100 children will be sampled in each group.

NCT ID: NCT03842345 Withdrawn - Healthy Clinical Trials

DELPhI Evaluation of Psychiatric Conditions

Start date: March 2020
Phase:
Study type: Observational

DELPhI acquisition and analysis software, a QuantalX Neuroscience development, which is designed to measure, analyze, and display brain electrical activity of human electroencephalogram (EEG), to transcranial magnetic stimulation (TMS), will be used to evaluate different psychiatric conditions.

NCT ID: NCT03834766 Completed - ADHD Clinical Trials

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

Start date: February 6, 2019
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy of AMPH ER TAB compared to placebo in adult patients with ADHD aged 18 to 60 years.

NCT ID: NCT03832413 Completed - Healthy Clinical Trials

Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders

Start date: April 23, 2018
Phase:
Study type: Observational

We use Transcranial magnetic stimulation (TMS), combined with simultaneous registration of electroencephalograph (EEG),for examining human cortical functionality. TMS-EEG is a noninvasive brain stimulation method that allows to study human cortical function in vivo. EEG provides an opportunity to directly measure the cerebral response to TMS, measuring the cortical TMS Evoked potential (TEP). In this study we measure TEPs, in a wide variety of neurological conditions and healthy as a measure of cerebral reactivity across wide areas of neocortex.

NCT ID: NCT03799029 Not yet recruiting - ADHD Clinical Trials

Effects of a Cognitive Training Program With Game Elements Among ADHD

CogtrainADHD
Start date: February 20, 2019
Phase: N/A
Study type: Interventional

This study examines the impact of cognitive training among participants with ADHD in Switzerland